Journal:
:hepatitis monthly
0
kamuran turker department of infectious diseases, ministry of health bagcilar state hospital, istanbul, turkey; department of infectious diseases, ministry of health bagcilar state hospital, istanbul, turkey. tel: +90-2124404000, fax: +90-2124404242
betul tas department of dermatology, ministry of health bagcilar state hospital, istanbul, turkey
murat ozkaya department of physical medicine and rehabilitation, ministry of health bagcilar state hospital, istanbul, turkey
ebru tas department of gastroenterology, dumlupinari university faculty of medicine, evliya celebi research and training hospital, kutahya, turkey
aysel caglar department of pathology, ministry of health bagcilar state hospital, istanbul, turkey
umit seza tetikkurt department of pathology, ministry of health bagcilar state hospital, istanbul, turkey
introduction various types of dermatological manifestations have been reported due to hepatitis c virus (hcv) infection and antihcv therapy. some of them have been described during ifn-based therapies. peg-ifn-α-2a/rbv combination is used as the international standard of treatment for hcv infection for a long time. the combination therapy yields an adverse-event profile similar to standard int...
